CANDO: A Compiled Programming Language for Computer-Aided Nanomaterial Design and Optimization

European Lisp Symposium · 3K views · 2016 · 28:10

Open on YouTube

Functional programmingChemistryCompilers, interpreters & program analysistalkdated

Why Hacker News recommends it

Recommended as one of the best talks of the symposium for the unusual scope of applying Lisp to molecular design.

What it is

Christian Schafmeister presents CANDO at the 2016 European Lisp Symposium. It is a compiled Lisp-based language for designing macromolecules and nanoscale materials, built on the Clasp implementation of Common Lisp.

Recommended by 2 HN commenters across 1 different months, 2016 to 2019.

What Hacker News said

Recommends krzychukula · 2016-05 · on “European Lisp Symposium 2016”

Best talks in my opinion: * [this video] * [LINK] Notable mentions: * [LINK] * [LINK] * [LINK] I liked OpenGL lightning talk as well: * [LINK]

Recommends agumonkey · 2016-05 · on “European Lisp Symposium 2016”

> [this video] no wonder CANDO is impressive, the scope and fields involved are pretty rare... I'm very eager to learn if C. Schafmeister work will bear 'disruptive fruits'. ps: a talk about clasp [LINK]

Cites TeMPOraL · 2017-06 · on “AI and Robotics in Agriculture in Japan [video]”

[this video] Here's the video from last year's ELS. At the beginning of it he actually explains some of the reasoning - i.e. proteins are cool and powerful, but a) too hard to design, and b) too fragile.

Cites e12e · 2017-07 · on “Back to the Future: Lisp as a Base for a Statistical Computing System [pdf]”

My initial thought was that this was about a project building atop of clasp, like CANDO: [this video] [LINK] [LINK] But this does seem a bit more like Julia? "Julia: to Lisp or not to Lisp?" [LINK] Then there's also the Axiom system, which I guess is primarily for symbolic computation, but I don't know if it might make sense to use it as a building block for statistical software? [LINK]

Cites StreamBright · 2019-05 · on “My Husband Became a Poster Child of the Post-Antibiotic Era”

I wish there were a nanotechnology startup that would address MRSA. In theory, you can develop nanobots that attack specific types of bacteria. Not sure if this would work: [this video]